Tbx21-flox Mouse
一般名
Tbx21-flox
製品ID
S-CKO-18354
背景情報
C57BL/6JCya
系統ID
CKOCMP-57765-Tbx21-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Tbx21-flox Mouse(カタログ番号S-CKO-18354)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Tbx21-flox
系統ID
CKOCMP-57765-Tbx21-B6J-VB
遺伝子名
製品ID
S-CKO-18354
遺伝子別名
TBT1, Tbet, Tblym
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 11
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000001484
NCBIトランスクリプトID
NM_019507
ターゲット領域
Exon 2~3
有効領域の大きさ
~2.8 kb
遺伝子研究の概要
TBX21, also known as T-bet, is a crucial transcription factor that plays a vital role in coordinating the type 1 immune response. It is involved in multiple biological processes and has been associated with various disease-related pathways [1,2,3,4,5,8].
In colorectal cancer, TBX21 expression is decreased compared to normal tissue, and is negatively correlated with TNM stages. Ectopic expression of TBX21 inhibits cell proliferation, promotes apoptosis, and suppresses metastasis both in vitro and in vivo, via ARHGAP29/RSK/GSK3β-dependent and MYCT1/ZO-1 signaling-dependent manners [1,7]. In microsatellite-stable colorectal cancer, Fusobacterium nucleatum can induce Tbx21 promoter H3K27 acetylation and expression in CD8+ T cells, and TBX21 transcriptionally represses PD-1, alleviating CD8+ T cell exhaustion and promoting effector function, thus facilitating anti-PD-1 therapy [2]. In CMS1 subtype colorectal cancer, high TBX21 expression and low methylation are associated with a survival advantage, and it may be regulated by the TP53/P53 pathway [3].
In late-onset Alzheimer's disease, TBX21 mRNA expression is elevated in the leukocytes of peripheral blood, and the TT genotype of rs41515744 plays a protective role [4]. In periapical lesions, the TBX21-1993 T allele and TC/CC genotypes predispose to Th1-type immune response development in vitro and influence immune response polarization in vivo [5]. In Asian seabass, tbx21 is associated with resistance against viral nervous necrosis (VNN), with overexpression reducing NNV replication [6].
In obesity, ablation of Tbx21 specifically in B cells reduces inflammatory cytokines and macrophages in adipose tissue, ameliorating metabolic symptoms [8]. In Japanese patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), PTCL-TBX21 shows different clinicopathological features and better prognosis compared to PTCL-GATA3 [9].
In conclusion, TBX21 is essential for the type 1 immune response and is involved in numerous disease-related processes. Studies, including those using in vivo models (although not all are KO/CKO mouse models), have revealed its role in cancers, neurodegenerative diseases, inflammatory conditions, and infectious diseases in fish, providing insights into potential therapeutic targets and disease mechanisms.
References:
1. Jiang, Xinyu, Du, Wenfei, Yang, Chenglong, Huang, Yongming, Shen, Wenzhi. 2023. TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner. In Cellular oncology (Dordrecht, Netherlands), 46, 1269-1283. doi:10.1007/s13402-023-00809-6. https://pubmed.ncbi.nlm.nih.gov/37067748/
2. Wang, Xueliang, Fang, Yi, Liang, Wei, Sung, Joseph J Y, Yu, Jun. 2024. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. In Cancer cell, 42, 1729-1746.e8. doi:10.1016/j.ccell.2024.08.019. https://pubmed.ncbi.nlm.nih.gov/39303724/
3. Shen, Yuanyuan, Nussbaum, Yulia I, Manjunath, Yariswamy, Shyu, Chi-Ren, Mitchem, Jonathan B. 2022. TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer. In Cancers, 14, . doi:10.3390/cancers14194594. https://pubmed.ncbi.nlm.nih.gov/36230517/
4. Fatemi Langroudi, S R, Zeinaly, M, Ajamian, F. 2023. TBX21, the Master regulator of the type 1 immune response, overexpresses in the leukocytes of peripheral blood in patients with late-onset Alzheimer's disease. In Immunity & ageing : I & A, 20, 59. doi:10.1186/s12979-023-00385-1. https://pubmed.ncbi.nlm.nih.gov/37950255/
5. Colavite, Priscila Maria, Cavalla, Franco, Garlet, Thiago Pompermaier, Silva, Renato Menezes, Garlet, Gustavo Pompermaier. 2018. TBX21-1993T/C polymorphism association with Th1 and Th17 response at periapex and with periapical lesions development risk. In Journal of leukocyte biology, 105, 609-619. doi:10.1002/JLB.6A0918-339R. https://pubmed.ncbi.nlm.nih.gov/30548981/
6. Wong, Joey, Yang, Zituo, Wang, Le, Sun, Fei, Yue, Gen Hua. 2024. Tbx21 gene and its association with resistance against viral nervous necrosis (VNN) in Asian seabass, Lates calcarifer. In Marine life science & technology, 6, 679-689. doi:10.1007/s42995-024-00234-0. https://pubmed.ncbi.nlm.nih.gov/39620089/
7. Yang, Xiaowen, Shen, Xinzhuang, Liu, Zongjun, Huang, Yongming, Shen, Wenzhi. 2025. TBX21 inhibits colorectal cancer metastasis through ARHGAP29/GSK3β inhibitory signaling- and MYCT1/ZO-1 signaling-dependent manner. In International journal of biological sciences, 21, 328-345. doi:10.7150/ijbs.97920. https://pubmed.ncbi.nlm.nih.gov/39744435/
8. Hägglöf, Thomas, Vanz, Carlo, Kumagai, Abigail, Shute, Travis, Leadbetter, Elizabeth A. 2022. T-bet+ B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity. In Cell metabolism, 34, 1121-1136.e6. doi:10.1016/j.cmet.2022.07.002. https://pubmed.ncbi.nlm.nih.gov/35868310/
9. Shimasaki, Yasumasa, Miyoshi, Hiroaki, Kawamoto, Keisuke, Suzuki, Ritsuro, Ohshima, Koichi. 2024. Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients. In Cancer medicine, 13, e6793. doi:10.1002/cam4.6793. https://pubmed.ncbi.nlm.nih.gov/38234210/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
